Contrad Swiss SA

Contrad Swiss is a life sciences company advancing non-invasive solutions in musculoskeletal and aesthetic regenerative medicine. Our core is SIGMOLECS, a proprietary technology combining peptides with hyaluronic acid, acting directly at the site of application. Our portfolio includes medical devices for orthopaedics, sports medicine, rheumatology, pain therapy and rehabilitation, and solutions for aesthetic medicine offering quick post-procedure recovery and long-term optimization of skin’s regenerative capacity. All products for medical promotion are made in EU/Swiss facilities.